4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-15-052576
Executive Vice President R&D sold 50,000 shares at $10.12 ($506,000)
- Executive Vice President R&D acquired 50,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LEBEL FRANCOIS Executive Vice President R&D | 2015-06-09 | Option exercise | +50,000 | $4.34 | $217,000 | 50,000 | D |
| LEBEL FRANCOIS Executive Vice President R&D | 2015-06-09 | Sale | −50,000 | $10.12 | $506,000 | 0 | D |
| Derivatives | |||||||
| LEBEL FRANCOIS Executive Vice President R&D | 2015-06-09 | Option exercise · Stock Option (right to buy) | −50,000 | 100,000 | D | ||
| Open-market sales · 50,000 sh · avg $10.12 · $506,000 | |||||||
Loading xslF345X03/doc4.xml…